# Prevention of Treatment Induced Neuropathy in Multiple Myeloma

> **NCT01283997** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 79 (actual)

## Conditions studied

- Myeloma

## Interventions

- **OTHER:** Placebo
- **DRUG:** Minocycline

## Key facts

- **NCT ID:** NCT01283997
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-25
- **Primary completion:** 2022-08-22
- **Final completion:** 2022-08-22
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2024-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01283997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01283997, "Prevention of Treatment Induced Neuropathy in Multiple Myeloma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01283997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*